Christopher L. Hamblett

Statistics

Publications

Citations

631

H-Index

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Columbia University

Christopher L. Hamblett is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, enzyme inhibition, and pharmacology.

Publications per year

2000–2014

Publications

Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Joey L. Methot, Prasun K. Chakravarty, Mélissa Chénard et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 187 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +10

Total Synthesis of Leucascandrolide A

Keith R. Hornberger, Christopher L. Hamblett, James L. Leighton · Journal of the American Chemical Society · 2000 · 185 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Joey L. Methot, Christopher L. Hamblett, Dawn M. Mampreian et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors

Christopher L. Hamblett, Joey L. Methot, Dawn M. Mampreian et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Strained silacycle-catalyzed asymmetric Diels–Alder cycloadditions: the first highly enantioselective silicon Lewis acid catalyst

Katsumi Kubota, Christopher L. Hamblett, Xiaolun Wang et al. · Tetrahedron · 2006 · 42 citations

Natural Sciences, Chemical Engineering, Chemistry +12

1–5 of 10